Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
05/1996
05/30/1996WO1996015786A2 Oral compositions containing ondansetron
05/30/1996WO1996015785A1 Freeze-dried ondansetron compositions
05/30/1996WO1996015782A1 A method for treating vascular headaches
05/30/1996CA2206876A1 18,19-dinor-vitamin d compounds
05/30/1996CA2206873A1 18-nor-vitamin d compounds
05/30/1996CA2205969A1 Aminomethyl aryl compounds; dopamine receptor subtype selective ligands
05/30/1996CA2205807A1 Fusion proteins with cytotoxic activity against cells overexpressing erbb2-4
05/30/1996CA2205661A1 Piperazine, piperidine & tetrahydropyridine derivatives useful as 5-ht1 receptor agonists
05/30/1996CA2205540A1 A method of identifying cftr-binding compounds useful for activating chloride conductance in animal cells
05/30/1996CA2205356A1 Modified proteinase inhibitors
05/29/1996EP0713915A1 Hog cholera virus vaccine and diagnostic
05/29/1996EP0713875A1 Sulfonamides
05/29/1996EP0713864A1 Substituted benzoylguanidines, process for their preparation, their use as medicament of diagnostic agent as well as medicaments containing them
05/29/1996EP0713704A1 2-Amino-1,3-thiazines as nitric oxide synthase inhibitors
05/29/1996EP0713701A1 2-Bromomelatonin in the therapy of sleep disorders
05/29/1996EP0713653A1 Fortified fruit juice
05/29/1996EP0713529A1 NEW GROWTH/DIFFERENTIATION FACTOR OF THE TGF-$g(b) FAMILY
05/29/1996EP0713527A1 Fungicidal methods and compositions for killing yeast and sporular microorganisms
05/29/1996EP0713495A1 Methods of enhancing bioactivity of chemokines
05/29/1996EP0713484A1 Inhibitors of biogenic amine transporters
05/29/1996EP0713483A1 Amidine derivatives with nitric oxide synthetase activities
05/29/1996EP0713394A1 Method of preventing neutrophil mediated connective tissue damage
05/29/1996EP0713393A1 Estrogenic compounds as anti-mitotic agents
05/29/1996EP0679089A4 Methods for promoting cartilage matrix formation.
05/29/1996EP0618811A4 Proteolytic mixture containing escharase and method of isolating same.
05/29/1996EP0589037B1 Indian derivative and thromboxane antagonist containing the same
05/29/1996EP0558647B1 Ligand-mediated immunofunctional hormone binding protein assay method
05/29/1996EP0415924B1 Regulation of cell proliferation and differentiation using peptides
05/29/1996CN1123276A Cycloheptimidazole derivatives, method of manufacturing the same and therapeutic agents containing these compounds
05/29/1996CN1123185A Immune couplet
05/29/1996CN1123158A "Funaowan"-medicinal pill for recovering brains and production technology thereof
05/29/1996CN1031880C Process for preparing novel analogs of peptidase substrates
05/29/1996CN1031859C Air treatment plant for foodstuffs
05/29/1996CA2163840A1 Potentiation of drug response
05/28/1996US5521315 Olefin substituted long chain compounds
05/28/1996US5521297 Nucleic acids encoding human metabotropic glutamate receptors
05/28/1996US5521213 Nonsteroid antiinflammatory agents
05/28/1996US5521209 N-substituted azabicyclo[3.2.0]heptane derivatives as neuroleptics, the preparation and use thereof
05/28/1996US5521206 Hypotensive agents, treatment of atherosclerosis
05/28/1996US5521199 Piperidinyl compounds as neurokinin receptor antagonists
05/28/1996US5521197 Analgesics using serotonin antagonist
05/28/1996US5521191 Method for treatment of arterial stenosis
05/28/1996US5521185 Methods for inhibiting graft rejection and IL-1 production
05/28/1996US5521182 1,2,3,4 tetrahydropteridinone cyclic amide derivatives
05/28/1996US5521177 Angiotensin antagonist for cardiovascular disorders such as ischemia or central nervous system disorders such as cognitive functions, depression, alzheimer's disease or parkinson's syndrome
05/28/1996US5521170 Benzamide derivatives and pharmaceutical composition comprising the same
05/28/1996US5521156 Cyclic neurokinin A antagonists
05/28/1996US5520926 Wound dressings
05/28/1996CA1338352C 2-substituted quinolines
05/26/1996CA2163724A1 2-amino-1,3-thiazines as inhibitors of nitric oxide synthase
05/25/1996CA2163598A1 Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
05/24/1996CA2163466A1 Fortified fruit juices
05/23/1996WO1996015249A1 High level expression and facile purification of proteins, peptides and conjugates for immunization, purification and detection applications
05/23/1996WO1996015234A2 Lipid-splitting enzyme
05/23/1996WO1996015222A1 HUMAN MutT2
05/23/1996WO1996015147A1 Human stanniocalcin-alpha
05/23/1996WO1996015129A1 Oxazolyl- and thiazolylimidazo-benzo- and thienodiazepines and their use as medicaments
05/23/1996WO1996015128A2 6-ARYL PYRIDO[2,3-d]PYRIMIDINES AND NAPHTHYRIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION
05/23/1996WO1996015125A1 Nonpeptide endothelin antagonists
05/23/1996WO1996015120A1 Aminotetrazole derivatives useful as nitric oxide synthase inhibitors
05/23/1996WO1996015109A1 Endothelin antagonists
05/23/1996WO1996015108A1 Pyrrolidinyl di-carboxylic acid derivatives as metabotropic glutamate receptor agonists
05/23/1996WO1996015096A1 Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives as matrix metalloprotease inhibitiors
05/23/1996WO1996014868A1 Acne treating-wound healing compositions containing a pyruvate, an antioxidant and a mixture of fatty acids
05/23/1996WO1996014858A1 Use of angiotensin ii fragments and analogs thereof in tissue repair
05/23/1996WO1996014857A1 Multicatalytic protease inhibitors
05/23/1996WO1996014852A1 Composition of cisplatin in combination with 2,2'-dithio-bis(ethanesulfonate) (dimesna)
05/23/1996WO1996014846A1 Dihydropyrimidines and uses thereof
05/23/1996WO1996014845A1 Nk-1 receptor antagonists for the treatment of eye disorders
05/23/1996WO1996014844A1 Cyclic amidine analogs as inhibitors of nitric oxide synthase
05/23/1996WO1996014843A3 Pharmaceutical pyrazole compositions useful as inhibitors of protein kinases
05/23/1996WO1996014843A2 Pharmaceutical pyrazole compositions useful as inhibitors of protein kinases
05/23/1996CA2205016A1 Nk-1 receptor antagonists for the treatment of eye disorders
05/23/1996CA2204914A1 High level expression and facile purification of proteins, peptides and conjugates for immunization, purification and detection applications
05/23/1996CA2204908A1 Lipid cleavage enzyme
05/23/1996CA2204767A1 Pyrrolidinyl di-carboxylic acid derivatives as metabotropic glutamate receptor agonists
05/23/1996CA2204145A1 Acne treating-wound healing compositions containing a pyruvate, an antioxidant and a mixture of fatty acids
05/23/1996CA2203517A1 Pharmaceutical pyrazole compositions useful as inhibitors of protein kinases
05/23/1996CA2202760A1 Multicatalytic protease inhibitors
05/23/1996CA2202051A1 Nonpeptide endothelin antagonists
05/22/1996EP0712864A2 Non-absorbable synthetic sulfated polysaccharides
05/22/1996EP0712837A2 Ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes and 3-aminochromanes
05/22/1996EP0712629A1 Acyl deoxyribonucleoside derivatives and uses thereof
05/22/1996EP0712628A2 Methods of inhibiting bone loss
05/22/1996EP0712626A2 Use of R,S-(+/-)-alpha-Lipoic acid, S-(-)-alpha-Lipoic acid in reduced or oxidized form or their metabolites as well as their salts, esters, amides for the manufacture of rheological agents
05/22/1996EP0712493A1 A method for preparing and selecting pharmaceutically useful non-peptide compounds from a structurally diverse universal library
05/22/1996EP0712397A1 Amide derivatives as 5ht1d receptor antagonists
05/22/1996EP0712390A1 Succinamide derivatives, processes for their preparation and their use as gelatinase and collagenase inhibitors
05/22/1996EP0712389A1 Therapeutic compound - fatty acid conjugates
05/22/1996EP0712388A1 Use of phenols and phenol derivates as medicaments with fibrinogen-reducing effect
05/22/1996EP0712387A1 2-aminoindans as selective dopamine d3 ligands
05/22/1996EP0712303A1 Skin patches and methods for providing testosterone
05/22/1996EP0637299B1 20-methyl-substituted vitamin d derivates
05/22/1996EP0521914B1 A method for regulating neuron development and maintenance
05/22/1996EP0502081B1 Proliferative action of leukaemia inhibitory factor on satellite cells
05/22/1996CN1123005A Compositions, for inhibition, control and regression of angiogenesis, containing hyaluronic acid and nsaid
05/22/1996CN1122804A 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
05/21/1996US5519163 Inhibitors of phosphoinositide-specific phospholipase C
05/21/1996US5519138 Angiotensin antagonist
05/21/1996US5519134 Pyrrolidine-containing monomers and oligomers
1 ... 1372 1373 1374 1375 1376 1377 1378 1379 1380 1381 1382 1383 1384 1385 1386 1387 1388 1389 1390 1391 1392 ... 1564